Forrester Research Q2: Potential Growth Inflection Ahead As Shares Remain Cheap

Forrester Research (FORR) reported continued revenue and earnings declines in Q2, though expectations suggest Contract Value stabilization in the second half of 2024. Despite trading at a low 8.1x earnings with a $100 million net cash position, the company faces ongoing challenges from elevated client churn, particularly among smaller accounts, and the broader impact of AI, which tempers the positive outlook from its own Izola AI offering. Consequently, the analyst maintains a cautious "Hold" rating, awaiting clear signs of revenue stabilization.

Analysis

Forrester Research (FORR) continues to face operational headwinds, as reflected in its Q2 results which showed another period of declining revenue and earnings. Despite this, management anticipates a potential inflection point, guiding for Contract Value (CV) to stabilize in the second half of the year. The company's valuation appears compelling, trading at just 8.1x earnings with a robust balance sheet supported by a $100 million net cash position. However, this low multiple reflects significant underlying risks. Persistent and elevated churn, particularly among smaller clients, remains a primary concern that undermines revenue stability. Furthermore, while the company is seeing increased adoption of its own AI offering, Izola, the broader competitive threat from AI continues to loom over its traditional research business model. The current situation presents a classic value-versus-risk scenario, where the attractive valuation is counterbalanced by a lack of clear, tangible evidence of a business turnaround.

Key Decisions for Investors

• Investors should closely monitor upcoming quarterly reports for confirmation of the expected stabilization in Contract Value, as this is the primary catalyst for a potential re-rating of the stock.
• While the 8.1x earnings multiple and $100 million net cash position are attractive, these must be weighed against the significant risks of elevated client churn and broader AI-driven industry disruption.
• A cautious or neutral stance is prudent until there is clear evidence that revenue has stabilized and the company's Izola AI offering is effectively mitigating competitive pressures.